The invention relates to a solid .sup.9-THC composition containing .sup.9-THC and a powder former and having a molar ratio of .sup.9-THC to powder former to form a flowable .sup.9-THC powder. The powder former is selected from the group consisting of adenine, aspartame, caffeine, lactose, mannitol, nicotinamide, -nicotinamide adenine dinucleotide, pipecolic acid, saccharin, aspartic acid, glutamic acid, glutamine, histidine, leucine, methionine, phenylalanine, proline, serine, tryptophan, valine, Epigallocatechin Gallate (EGCG), 2-Hydroxypropyl-beta-cyclodextrin (HPbCD), and Trimethyl-beta-cyclodextrin (TOMBC) and mixtures thereof. The invention also relates to methods of making a solid .sup.9-THC composition of the invention. The .sup.9-THC may be synthetic .sup.9-THC or may be extracted .sup.9-THC. The invention provides pharmaceutical or nutraceutical composition containing a solid .sup.9-THC composition of the invention and a pharmaceutically- or nutraceutically-acceptable carrier where .sup.9-THC is present in a pharmaceutically or nutraceutically effective amount. The invention also provides methods of treating a disease, disorder, or condition by administering to a patient in need thereof a therapeutically effective amount of a solid .sup.9-THC composition. A solid .sup.9-THC composition of the invention may also be incorporated into food and beverage products.

Various aspects of this patent document relate to liquid compositions comprising cannabidiol, which have either freezing points or glass-liquid transition temperatures less than the melting point of pure cannabidiol.

This invention is directed to a Self-Emulsifying Drug Delivery System (SEDDS) of Punicic Acid combined with neuroprotective natural products to treat, prevent, delay onset, prevent or reverse neurodegenerative disease.

The present invention relates to skin care preparations comprising callus-derived pluripotent cells of a plant of the genus Cannabis, including Cannabis sativa I., and Cannabis indica, compositions comprising same and use thereof for promoting skin health and appearance.

The present invention relates to a ready to drink beverage composition comprising fermented hemp or fermented hemp extract. A further aspect of the invention is a method of preparing a ready to drink beverage composition.

The present invention relates to compositions comprising cannabinoids together with an additional active ingredient. The present invention also relates to pharmaceutical compositions, dosage forms and methods of treating neurological disorders by administering the composition to a patient in need thereof.

The present disclosure relates to compositions, including, transdermal delivery systems useful as topical analgesics including an effective amount of a compound (e.g., psilocybin) for treating drug addiction (e.g. opioid addiction) and menthol and optionally cannabinoids wherein the menthol component can be a stabilized menthol composition comprising menthol and at least one menthol stabilizer compound including undecylenic acid methyl ester, undecylenic acid or a salt of undecylenic acid.

Provided are therapeutic combinations, pharmaceutical compositions, and pharmaceutical kits comprising fungi (e.g., Psilocybe spp. fungi), plants (e.g., Cannabis spp., Dipteryx spp.), and algae (e.g., from the family Bangicaeae, including Pyropia spp. and Porphyra spp.), including extracts and bioactive molecules derived therefrom. Methods of producing the disclosed combinations, compositions, and kits are also provided, such as using natural, biosynthetic, or synthetic means. Further provided are methods of using the disclosed combinations, compositions, and kits in the treatment of medical conditions, and in particular for treating inflammatory diseases and conditions, for which the disclosed combinations are demonstrated to provide significant advantages.

This disclosure relates to non-naturally occurring hemp extracts comprising cannabinoids and related treatment methods.

The present invention relates to a composition comprising (i) an extract of Crocus sativus comprising at least safranal, and (ii) an extract of Cannabis sativa comprising cannabidiol (CBD) and uses thereof as a pharmaceutical product, a food supplement, a nutritional product, a cosmetic product, or a liquid suitable for electronic cigarettes.